| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.7M | — | +40.2% |
| Cost of Revenue | $0 | — | -100.0% |
| R&D Expense | $11.8M | — | -45.1% |
| SG&A Expense | $6.9M | — | -56.4% |
| Operating Income | $15.1M | — | +213.1% |
| Net Income | $39.2M | — | +248.7% |
| EPS (Basic) | $1.03 | — | +200.0% |
| EPS (Diluted) | $1.02 | — | +199.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.0M | +1067.3% | +89.3% |
| Accounts Receivable | $6.6M | +258.4% | +1753.7% |
| Current Assets | $95.3M | -28.6% | +311.8% |
| Total Assets | $186.5M | -17.8% | -6.9% |
| Current Liabilities | $249.2M | -23.0% | +19.7% |
| Long-term Debt | $30.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$36.0M | — | -40.3% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $69.0M | — | — |
| Financing Cash Flow | -$993K | — | -127.6% |
| Free Cash Flow | -$36.0M | — | -40.3% |
| -10.1% |
| Stockholders' Equity | -$221.2M | +18.4% | +35.3% |